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Abstract
Hospital construction and renovation activities are the main cause of healthcare-associated fungal outbreaks. Infection control risk assessments (ICRAs) for renovation and construction decrease the risk of healthcare-associated fungal outbreaks, but they are typically not performed in developing countries. We reviewed an outbreak investigation to limit the construction-related fungal infections in a COVID-19 ICU
in a resource-limited setting.
(Received 17 December 2021; accepted 7 February 2022)

Invasive pulmonary aspergillosis (CAPA) associated with coronavirus disease 2019 (COVID-19) has been reported to occur in
3.3%–33.3% of intensive care unit (ICU) patients with COVID19, and CAPA is associated with a 28.5%–100% mortality rate.1,2
Immune dysregulation, defective reactive oxygen species production, together with epithelial barrier damage of respiratory tract
from COVID-19 immunopathology, are suspected mechanisms
predisposing patients to CAPA.3 Invasive fungal infection (IFI)
is a well-known complication in immunocompromised patients.
Major predisposing conditions include corticosteroid therapy,
comorbidities (eg, diabetes mellitus, chronic pulmonary disease),
and prolonged or inappropriate antibiotic exposure.4 Notably,
construction and demolition work accounted for 49% of healthcare-associated IFI outbreaks due to fungal spore exposure.5
Therefore, the occurrence of 2 or more cases of IFI in a short period
(2–6 months) should be considered an outbreak and requires
prompt investigation.6
Outbreak investigation
During April 1–30, 2021, at Thammasat University Hospital
(Prathum Thani, Thailand), the first case of aspergillosis was
detected in a COVID-19 ICU patient, followed by 3 additional
Author for correspondence: Anucha Apisarnthanarak, MD, Division of Infectious
Diseases, Faculty of Medicine, Thammasat University, Prathum Thani, Thailand,
10120. E-mail: anapisarn@yahoo.com
Cite this article: Sathitakorn O, et al. (2022). Strategies to limit invasive fungal infection
in a coronavirus disease 2019 (COVID-19) intensive care unit: The role of infection
prevention for renovation and construction in resource-limited settings. Antimicrobial
Stewardship & Healthcare Epidemiology, https://doi.org/10.1017/ash.2022.35

cases in the same COVID-19 ICU, accounting for 16% of the 25
patients in the ICU within a month. All 4 patients were diagnosed
with probable invasive pulmonary aspergillosis by positive fungal
cultures obtained by bronchoalveolar lavage and positive serum
galactomannan based on consensus definitions of invasive fungal
disease from the European Organization for Research and
Treatment of Cancer and the Mycoses Study Group Education
and Research Consortium.7 The fungal culture of the first patient
revealed Aspergillus flavus, and cultures from the other 3 patients
yielded Aspergillus fumigatus. All of these patients died within 2
weeks after positive fungal cultures. After these patients were identified, an outbreak investigation was initiated based on a bundle of
key methods for preventing filamentous fungal infection associated with renovation and construction activities.4 The hospital epidemiologist performed an infection control risk assessment
(ICRA) of renovation and construction activity near the ICU.
Initial outbreak investigation steps included air sampling to measure airborne fungal bioburden at the front of ICU, the nursing station, the index patient anterooms, and rooms. Airborne fungal
bioburdens from air sampling were 235–290 CFU/m3 at all sites.
In this hospital, the baseline standard airborne fungal bioburden
was <500 CFU/m3 for the general unit and <150 CFU/m3 for
the ICU and operating room.8 Air pressures in the COVID-19 unit
were checked at the front of ICU, the nursing station, the index
patient anterooms, and the index patient rooms and measured
0, 0, −5, and −10 kPa, respectively. The hospital epidemiology
team assessed the standard of construction sites using the ICRA
for all renovation and construction activities and identified the
demolition work including removing the floor covering, ceiling
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tiles, case work, and new wall construction on the same floor as the
COVID-19 ICU. Based on the ICRA matrix, the patient population
was classified as the “highest risk group,” and the construction
project was classified as type C, leading to a designation of class
IV renovation/construction. (The ICRA matrix is available at
https://www.ashe.org/icra2.) After inspecting the construction site
to identify possible solutions, we instituted appropriate preventive
measures.
Following the outbreak investigation, focused preventive efforts
to reduce airborne fungal spores using the following interventions: site containment, installation of critical barriers to seal
construction areas from clinical areas, cleaning of construction
areas, use negative air-pressure handling of the construction site
using exhaust fans, and installing portable HEPA filters at the
construction site. Pressure at the ICU was recalibrated to be
þ10 kPa at the nursing station, −10 kPa in all anterooms,
and −20 kPa in all patient rooms. Additional interventions
included continuous monitoring and serial air sampling for airborne fungal bioburden at the front of ICU, the nursing station,
the index patient’s anterooms, and rooms. Our interventions
revealed a substantial reduction in airborne fungal bioburden
in the air; airborne fungal levels declined to 30–50 CFU/m3 at
all sites. Continued surveillance for healthcare-associated filamentous fungal infections during renovation and construction
was performed for an additional 6 months, and no additional
cases of aspergillosis in the same unit occurred.
In conclusion, hospital construction and renovations activities
are never ending, and they are the main cause of healthcare-associated fungal outbreaks,5 which pose a serious threat to immunocompromised hosts, including high-risk patients (eg, COVID-19
pneumonia patients). Following ICRA for renovation and construction decreases the risk of healthcare-associated fungal outbreaks. However, ICRAs are not typically performed in
developing countries, which may lead to healthcare-associated
fungal outbreaks in settings such as ICUs, hematologic wards,
and renal transplant units.6 Although uncommon, healthcareassociated fungal outbreaks must be suspected when 2 or more
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cases occur in a short period.6 Early outbreak investigation and
identification of the source are likely to play a key role in limiting
the spread of healthcare-associated fungal outbreaks. Such strategies, together with a full compliance with recommendations from a
multidisciplinary coordination team, will help limit the construction-related fungal infection in a COVID-19 ICU. National strategies are needed in developing countries to promote the use of
ICRA for renovation and construction to limit healthcare-associated fungal outbreaks.
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